Labcorp Executives Set for Morgan Stanley Healthcare Conference
Labcorp executives are scheduled to address investors during a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The session, slated for September 15 at 11:30 a.m. ET, offers a window into the diagnostic firm's current operational trajectory and its role in global clinical research.
The Burlington-based company, which currently employs nearly 71,000 people across 100 countries, will provide a live audio webcast of the event through its investor relations portal. The presentation will remain accessible for replay for 180 days following the conference date.
Labcorp maintains a significant footprint in the pharmaceutical sector, having supported more than 85% of all FDA-approved drugs and therapeutic products in 2025. With a volume exceeding 750 million tests performed annually, the company remains a primary service provider for hospitals, researchers, and individual patients seeking diagnostic clarity.
Comments (0)
No comments yet. Be the first!